Skeletal effects of adjuvant zoledronic acid and its cessation in women with early-stage breast cancer

被引:0
|
作者
Ramchand, Sabashini K. [1 ,2 ]
机构
[1] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Endocrinol & Metab Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Austin Hlth, Dept Med, 145 Studley Rd, Melbourne, VIC 3084, Australia
关键词
PATHOGENESIS; MECHANISMS; FRACTURES; THERAPY;
D O I
10.1093/jbmr/zjae120
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1203 / 1204
页数:2
相关论文
共 50 条
  • [31] Zoledronic acid is being investigated for the prevention of bone metastases in patients with early-stage breast cancer
    Coleman, R
    Gralow, J
    Bell, R
    Lipton, A
    [J]. BONE, 2004, 34 : S85 - S85
  • [32] Zoledronic acid 'benefits women with early breast cancer'
    Gnant, Michael
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (12) : 1615 - 1615
  • [33] Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
    Bender, Catherine M.
    Sereika, Susan M.
    Brufsky, Adam M.
    Ryan, Christopher M.
    Vogel, Victor G.
    Rastogi, Priya
    Cohen, Susan M.
    Casillo, Frances E.
    Berga, Sarah L.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 995 - 998
  • [34] Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins
    Pollock, YaoYao G.
    Blackford, Amanda L.
    Jeter, Stacie C.
    Wright, Jean
    Cimino-Mathews, Ashley
    Camp, Melissa
    Harvey, Susan
    Asrari, Fariba
    Schoenborn, Nancy L.
    Stearns, Vered
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 291 - 296
  • [35] Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins
    YaoYao G. Pollock
    Amanda L. Blackford
    Stacie C. Jeter
    Jean Wright
    Ashley Cimino-Mathews
    Melissa Camp
    Susan Harvey
    Fariba Asrari
    Nancy L. Schoenborn
    Vered Stearns
    [J]. Breast Cancer Research and Treatment, 2016, 160 : 291 - 296
  • [36] Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
    Partridge, Ann H.
    LaFountain, Andrea
    Mayer, Erica
    Taylor, Brooke S.
    Winer, Eric
    Asnis-Alibozek, Aviva
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 556 - 562
  • [37] Effect of adjuvant zoledronic acid (ZOL) on disseminated tumor cells (DTC) in the bone marrow (BM) of women with early-stage breast cancer (ESBC): Updated results.
    Greenberg, S.
    Park, J. W.
    Melisko, M. E.
    Goga, A.
    Moasser, M. M.
    Anderson, M.
    Scott, J. H.
    Petrillo, L. A.
    Moore, D. H.
    Rugo, H. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
    Philippe L. Bedard
    Angelo Di Leo
    Martine J. Piccart-Gebhart
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 22 - 36
  • [39] Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
    Bedard, Philippe L.
    Di Leo, Angelo
    Piccart-Gebhart, Martine J.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (01) : 22 - 36
  • [40] Osteoporosis after adjuvant treatment for early-stage breast cancer
    Christensen, Carina Orts
    Jensen, Maj-Britt
    Hermann, Anne Pernille
    Ewertz, Marianne
    [J]. DANISH MEDICAL JOURNAL, 2020, 67 (11):